MKP1 mediates resistance to therapy in HER2-positive breast tumors

Demet Candas, Jian-Jian Li

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

Original languageEnglish (US)
Article numbere997518
JournalMolecular and Cellular Oncology
Volume2
Issue number4
DOIs
StatePublished - Oct 2 2015

Fingerprint

Breast Neoplasms
Mitogen-Activated Protein Kinase Phosphatases
Dual Specificity Phosphatase 1
Therapeutics
Phosphoric Monoester Hydrolases
Radiation
human ERBB2 protein

Keywords

  • breast cancer
  • HER2
  • mitochondria
  • MKP1
  • radioresistance

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine

Cite this

MKP1 mediates resistance to therapy in HER2-positive breast tumors. / Candas, Demet; Li, Jian-Jian.

In: Molecular and Cellular Oncology, Vol. 2, No. 4, e997518, 02.10.2015.

Research output: Contribution to journalArticle

@article{054532a7dc754cca89bf10a06f48be52,
title = "MKP1 mediates resistance to therapy in HER2-positive breast tumors",
abstract = "Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.",
keywords = "breast cancer, HER2, mitochondria, MKP1, radioresistance",
author = "Demet Candas and Jian-Jian Li",
year = "2015",
month = "10",
day = "2",
doi = "10.1080/23723556.2014.997518",
language = "English (US)",
volume = "2",
journal = "Molecular and Cellular Oncology",
issn = "2372-3556",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

TY - JOUR

T1 - MKP1 mediates resistance to therapy in HER2-positive breast tumors

AU - Candas, Demet

AU - Li, Jian-Jian

PY - 2015/10/2

Y1 - 2015/10/2

N2 - Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

AB - Mitogen-activated protein kinase phosphatase 1 (MKP1 or DUSP1) is an antiapoptotic phosphatase that is overexpressed in many cancers, including breast cancer. MKP1 expression is inducible in radiation-treated breast cancer cells, and correlates with human epidermal growth factor receptor 2 (ERBB2, HER2) expression. The role of MKP1 in therapy resistance suggests that targeting MKP1 in HER2-positive breast tumors may significantly enhance the efficacy of anti-HER2 and other anticancer therapies.

KW - breast cancer

KW - HER2

KW - mitochondria

KW - MKP1

KW - radioresistance

UR - http://www.scopus.com/inward/record.url?scp=85034048660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034048660&partnerID=8YFLogxK

U2 - 10.1080/23723556.2014.997518

DO - 10.1080/23723556.2014.997518

M3 - Article

AN - SCOPUS:85034048660

VL - 2

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

SN - 2372-3556

IS - 4

M1 - e997518

ER -